An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors

Name: An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
License: Public Domain

Guangzhou FineImmune Biotechnology Co., LTD.

ClinicalTrials.gov · Datasets · License: Public Domain

sarcoma, lung cancers, melanoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 405133
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.